Pharma-Biotech New Build Update: 227 New North American Facilities Represent $20 Billion Potential Capital Investment
Pharma-Biotech New Build Update: 227 New North American Facilities Represent $20 Billion Potential Capital Investment
Attachment: GL2Q07plants
There are currently 259 projects linked with the 227 plants, which translates into an impressive TIV of $90 million per site.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
